Transforming growth factor-beta differentially inhibits MyD88-dependent, but not TRAM- and TRIF-dependent, lipopolysaccharide-induced TLR4 signaling. (Q40476384)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Transforming growth factor-beta differentially inhibits MyD88-dependent, but not TRAM- and TRIF-dependent, lipopolysaccharide-induced TLR4 signaling.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

20 September 2017

Transforming growth factor-beta differentially inhibits MyD88-dependent, but not TRAM- and TRIF-dependent, lipopolysaccharide-induced TLR4 signaling. (English)

1 reference

Europe PubMed Central

20 September 2017

lipopolysaccharide

0 references

toll-like receptor

0 references

6

object named as

Moshe Arditi

1 reference

Europe PubMed Central

20 September 2017

author name string

Yoshikazu Naiki

1

1 reference

Europe PubMed Central

20 September 2017

Kathrin S Michelsen

2

1 reference

Europe PubMed Central

20 September 2017

Wenxuang Zhang

3

1 reference

Europe PubMed Central

20 September 2017

Shuang Chen

4

1 reference

Europe PubMed Central

20 September 2017

Terence M Doherty

5

1 reference

Europe PubMed Central

20 September 2017

language of work or name

0 references

publication date

28 December 2004

1 reference

Europe PubMed Central

20 September 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

20 September 2017

280

1 reference

Europe PubMed Central

20 September 2017

7

1 reference

Europe PubMed Central

20 September 2017

5491-5495

1 reference

Europe PubMed Central

20 September 2017

Coordinate regulation of cell growth and differentiation by TGF-beta superfamily and Runx proteins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400503200

21 January 2018

Smad-dependent and Smad-independent pathways in TGF-beta family signalling

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400503200

21 January 2018

New insights into TGF-beta-Smad signalling

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400503200

21 January 2018

Role of transforming growth factor beta in human disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400503200

21 January 2018

Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400503200

21 January 2018

TGF-beta: the missing link in CD4+CD25+ regulatory T cell-mediated immunosuppression

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400503200

21 January 2018

Redirection of B cell responsiveness by transforming growth factor beta receptor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400503200

21 January 2018

Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400503200

21 January 2018

Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400503200

21 January 2018

Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400503200

21 January 2018

TLR signaling: an emerging bridge from innate immunity to atherogenesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400503200

21 January 2018

Specific abrogation of transforming growth factor-beta signaling in T cells alters atherosclerotic lesion size and composition in mice.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400503200

21 January 2018

Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400503200

21 January 2018

Inferences, questions and possibilities in Toll-like receptor signalling

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400503200

21 January 2018

HMEC-1: establishment of an immortalized human microvascular endothelial cell line

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400503200

21 January 2018

Bacterial lipopolysaccharide activates nuclear factor-kappaB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400503200

21 January 2018

Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400503200

21 January 2018

Identification of distinct signaling pathways leading to the phosphorylation of interferon regulatory factor 3

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400503200

21 January 2018

Toll-like receptors in innate immunity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400503200

21 January 2018

The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400503200

21 January 2018

Regulatory functions of ubiquitination in the immune system

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400503200

21 January 2018

Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400503200

21 January 2018

Ecsit is required for Bmp signaling and mesoderm formation during mouse embryogenesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400503200

21 January 2018

Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400503200

21 January 2018

Circulating TNF-alpha, TGF-beta, and IL-10 in tuberculosis patients and healthy contacts

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400503200

21 January 2018

Aberrant Toll receptor expression and endotoxin hypersensitivity in mice lacking a functional TGF-beta 1 signaling pathway.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400503200

21 January 2018

Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400503200

21 January 2018

TGF-beta in atherosclerosis.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400503200

21 January 2018

Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400503200

21 January 2018

Infections in patients with cancer undergoing chemotherapy: aetiology, prevention, and treatment

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400503200

21 January 2018

Ubiquitin ligases and the immune response

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C400503200

21 January 2018

Identifiers

10.1074/JBC.C400503200

1 reference

Europe PubMed Central

20 September 2017

release_p6aukweubrc7jb4kqb3usct7w4

1 reference

https://api.fatcat.wiki/v0/release/p6aukweubrc7jb4kqb3usct7w4

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

20 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40476384&oldid=1835704828"